Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Benedictuson Nov 01, 2023 4:05am
301 Views
Post# 35710625

RE:We should know hopefully tomorrow

RE:We should know hopefully tomorrow
N0taP00p wrote: The trade volume is spiking.  Maybe it's the folks buying the new 5 years BOGO deal that are offloading existing shares, but wonder who's buying?

Also, my guess is they'll need at least  $1.5M per quarter.  So, hoping to see at least the lower end filled in this ongoing raise. Else, the hat will be passed around again in Q1 at a much lower price. 

Have you read the LIFE offering, specifically the Business Objectives and Milestones and Use of Available Funds sections? They outline all the specifics w.r.t. current working capital and overall expected costs incurred depending on whether the  minimum or maximum amounts are raised. It's nicely detailed and easy to estimate how the next 14 months should unfold from a cash burn perspective. With many potential catalysts during that time period I think cash could be much less of a concern. 

https://theralase.com/wp-content/uploads/2023/10/Theralase-Amended-LIFE-Offering-Document-v10-clean.pdf
<< Previous
Bullboard Posts
Next >>